Buteyko Based Remedial Breathing Therapy With Children With Asthma
Primary Purpose
Asthma
Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Buteyko based Remedial Breathing Therapy
Sponsored by

About this trial
This is an interventional treatment trial for Asthma focused on measuring asthma, Buteyko, remedial breathing, children
Eligibility Criteria
Inclusion Criteria:
- signed informed consent of the parents
- age 6- 15 years
- information and consent of the consulting doctor
- levels of asthma therapy 1-3
Exclusion Criteria:
- participation in another study
Sites / Locations
- Filderklinik
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Buteyko based Remedial Breathing Therapy
Waiting List
Arm Description
Buteyko based Remedial Breathing Therapy
Training in the course of the study
Outcomes
Primary Outcome Measures
Reduction of Betamimetics (-30%) at 3- and/or 6-month follow up
Secondary Outcome Measures
Asthma Control Questionnaire (ACQ)
Scores of the ACQ (Asthma Control Questionnaire)
Paediatric Asthma Quality of Life Questionnaire (PAQLQ)
Scores of PAQLQ (Paediatric Asthma Quality of Life Questionnaire)
ARCIM Questionnaire (AFB)
Scores of the AFB (ARCIM Questionnaire) regarding to asthma symptoms of the last 3 month (AFB is not validated)
Peak Flow
NO-measurement nasal and oral
Buteyko-Questionnaire
parameters of spirometry
Paediatric asthma caregiver´s quality of life questionnaire (PACQLQ)
Full Information
NCT ID
NCT02140086
First Posted
May 14, 2014
Last Updated
March 1, 2016
Sponsor
ARCIM Institute Academic Research in Complementary and Integrative Medicine
1. Study Identification
Unique Protocol Identification Number
NCT02140086
Brief Title
Buteyko Based Remedial Breathing Therapy With Children With Asthma
Study Type
Interventional
2. Study Status
Record Verification Date
March 2016
Overall Recruitment Status
Completed
Study Start Date
January 2014 (undefined)
Primary Completion Date
November 2014 (Actual)
Study Completion Date
November 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
ARCIM Institute Academic Research in Complementary and Integrative Medicine
4. Oversight
5. Study Description
Brief Summary
A randomized, controlled trial to investigate the effects of a buteyko based remedial breathing therapy on children with asthma regarding to their symptoms, use of medication and lung function tests.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
Keywords
asthma, Buteyko, remedial breathing, children
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
32 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Buteyko based Remedial Breathing Therapy
Arm Type
Experimental
Arm Description
Buteyko based Remedial Breathing Therapy
Arm Title
Waiting List
Arm Type
No Intervention
Arm Description
Training in the course of the study
Intervention Type
Behavioral
Intervention Name(s)
Buteyko based Remedial Breathing Therapy
Intervention Description
Buteyko based remedial Breathing Therapy after Dr. Buteyko
Primary Outcome Measure Information:
Title
Reduction of Betamimetics (-30%) at 3- and/or 6-month follow up
Time Frame
asthmaspezific parameters are measured before and after intervention as well as 3- and 6- month follow up
Secondary Outcome Measure Information:
Title
Asthma Control Questionnaire (ACQ)
Description
Scores of the ACQ (Asthma Control Questionnaire)
Time Frame
parameters are measured before and after intervention as well as 3- and 6- month follow up
Title
Paediatric Asthma Quality of Life Questionnaire (PAQLQ)
Description
Scores of PAQLQ (Paediatric Asthma Quality of Life Questionnaire)
Time Frame
parameters are measured before and after intervention as well as 3- and 6- month follow up
Title
ARCIM Questionnaire (AFB)
Description
Scores of the AFB (ARCIM Questionnaire) regarding to asthma symptoms of the last 3 month (AFB is not validated)
Time Frame
parameters are measured before and after intervention as well as 3- and 6- month follow up
Title
Peak Flow
Time Frame
parameters are measured before and after intervention as well as 3- and 6- month follow up
Title
NO-measurement nasal and oral
Time Frame
parameters are measured before and after intervention as well as 3- and 6- month follow up
Title
Buteyko-Questionnaire
Time Frame
parameters are measured before and after intervention as well as 3- and 6- month follow up
Title
parameters of spirometry
Time Frame
parameters are measured before and after intervention as well as 3- and 6- month follow up
Title
Paediatric asthma caregiver´s quality of life questionnaire (PACQLQ)
Time Frame
parameters are measured before and after intervention as well as 3- and 6- month follow up
10. Eligibility
Sex
All
Minimum Age & Unit of Time
6 Years
Maximum Age & Unit of Time
15 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
signed informed consent of the parents
age 6- 15 years
information and consent of the consulting doctor
levels of asthma therapy 1-3
Exclusion Criteria:
participation in another study
Facility Information:
Facility Name
Filderklinik
City
Filderstadt
State/Province
Baden-Württemberg
ZIP/Postal Code
70794
Country
Germany
12. IPD Sharing Statement
Learn more about this trial
Buteyko Based Remedial Breathing Therapy With Children With Asthma
We'll reach out to this number within 24 hrs